Effects of cryotherapy on high-dose melphalan-induced oral mucositis in pediatric patients undergoing autologous stem cell transplantation

被引:4
|
作者
Kawaguchi, Koji [1 ]
Umeda, Katsutsugu [2 ]
Takachi, Takayuki [1 ]
Ogura, Taemi [1 ]
Horikoshi, Yasuo [1 ]
Saida, Satoshi [2 ]
Kato, Itaru [2 ]
Hiramatsu, Hidefumi [2 ]
Adachi, Souichi [3 ]
Takita, Junko [2 ]
Watanabe, Kenichiro [1 ]
机构
[1] Shizuoka Childrens Hosp, Dept Hematol & Oncol, Shizuoka, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan
关键词
autologous stem cell transplantation; children; cryotherapy; melphalan; oral mucositis; TOTAL-BODY IRRADIATION; CONDITIONING REGIMENS; INDUCED STOMATITIS; MULTIPLE-MYELOMA; PREVENTION; CHILDREN; CHEMOTHERAPY; CANCER;
D O I
10.1002/pbc.28495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cryotherapy is a conventional method for preventing melphalan-induced oral mucositis (OM) in adult patients. We retrospectively examined the clinical benefits of cryotherapy in 41 pediatric patients undergoing autologous stem cell transplantation using a melphalan-etoposide-carboplatin regimen. Twenty-two patients received cryotherapy. The cumulative incidence of grade 3-4 OM was significantly lower in the cryotherapy group (57.1%) than in the noncryotherapy group (89.5%;P = .041). Multivariate analyses identified cryotherapy and the melphalan dose as independent factors for the lower occurrence of OM. The present study demonstrates the clinically significant efficacy of cryotherapy for preventing melphalan-induced OM in pediatric patients.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Oral Ciprofloxacin Prophylaxis in Patients Undergoing High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
    Tabarraee, Mahdi
    Tavakoli-Ardakani, Maria
    Mehdizadeh, Mahshid
    Ghadiani, Mojtaba
    Rezvani, Hamid
    Hajifathali, Abbas
    Khamsi, Samiyeh
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 : 159 - 163
  • [22] High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    ACTA HAEMATOLOGICA, 2020, 143 (04) : 381 - 387
  • [23] Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention
    Okada, Naoto
    Hanafusa, Takeshi
    Abe, Shinji
    Sato, Chiemi
    Nakamura, Toshimi
    Teraoka, Kazuhiko
    Abe, Masahiro
    Kawazoe, Kazuyoshi
    Ishizawa, Keisuke
    SUPPORTIVE CARE IN CANCER, 2016, 24 (09) : 3979 - 3985
  • [24] Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy
    Gustavo Henrique Rodrigues
    Graziella Chagas Jaguar
    Fabio Abreu Alves
    Andre Guollo
    Vanessa Oliveira Camandoni
    Aline Santos Damascena
    Vladmir Claudio Cordeiro Lima
    Lasers in Medical Science, 2017, 32 : 1089 - 1095
  • [25] Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide
    Ingole, P.
    Morkas, M.
    May, R.
    Hinman, B.
    Carrum, G.
    Kamble, R. T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S587 - S587
  • [26] Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis
    Lee, S. Y.
    Meehan, R. S.
    Seldin, D. C.
    Sloan, J. M.
    Quillen, K.
    Shelton, A.
    Brauneis, D.
    Sanchorawala, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1318 - 1322
  • [27] High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors
    Diaz, MA
    Vicent, MG
    Madero, L
    BONE MARROW TRANSPLANTATION, 1999, 24 (11) : 1157 - 1159
  • [28] High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors
    MA Diaz
    MG Vicent
    L Madero
    Bone Marrow Transplantation, 1999, 24 : 1157 - 1159
  • [29] Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies
    Gordillo, Christian A.
    Parmar, Sapna
    Blanco, Miranda
    Delille, Elsa M.
    Assal, Amer
    Mapara, Markus
    Reshef, Ran
    ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1863 - 1870
  • [30] Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning
    Oku, Saori
    Futatsuki, Toshiko
    Imamura, Yoshiko
    Hikita, Haruna
    Inada, Akemi
    Mizutani, Shinsuke
    Mori, Yasuo
    Kashiwazaki, Haruhiko
    SUPPORTIVE CARE IN CANCER, 2023, 31 (09)